By year end, the IDSA expects to make public its intent with regard to the 2006 Lyme guidelines -- whether they will stand as is, or be modified in part or in whole. The complete video record of the 1-day hearing, which was broadcast live online during the event, is expected to be available through the IDSA website this week. In the meantime, the IDSA is making all of the presentation materials available for download. The presenters included:
- Tina Garcia, Lyme Education Awareness Program Arizona (L.E.A.P. Arizona, Inc.), Mesa, AZ PDF
- Lorraine Johnson, JD, MBA, California Lyme Disease Association (CALDA), Ukiah, CA PDF
- Daniel Cameron, MD, International Lyme and Associated Diseases Society (ILADS), California PDF
- Phillip Baker, PhD, American Lyme Disease Foundation (ALDF), Bethesda, MD PDF
- Ben Luft, MD, The State University of New York, Stony Brook, NY PDF
- Allison Delong, MS, ILADS & The Center for Statistical Sciences, Brown University, Providence, RI PDF
- Barbara Johnson, PhD, Centers for Disease Control and Prevention, Fort Collins, CO
- David Volkman, MD, Nissequogue, NY
- Sam Donta, MD, Falmouth, MA PDF
- Eugene Shapiro, MD, IDSA & Yale University School of Medicine, New Haven, CT PDF
- Brian Fallon, MD, Columbia University Medical Center, New York, NY
- Sunil Sood, MD, Schneider Children's Hospital at North Shore, Manhasset, NY
- Ken Liegner, MD, ILADS, Armonk, NY PDF
- Allen Steere, MD, Massachusetts General Hospital & Harvard Medical School, Boston, MA PDF
- Steven Phillips, MD, ILADS, Wilton, CT PDF
- Arthur Weinstein, MD, Washington Hospital Center, Washington, DC PDF
- Raphael Stricker, MD, ILADS, San Francisco, CA PDF
- Gary Wormser, MD, IDSA & New York Medical College, Valhalla, NYPDF
Here is a press release issued by the International Lyme and Associated Diseases Society (ILADS) regarding the IDSA hearing, titled HISTORIC HEARINGS ON MOST CONTROVERSIAL DISEASE IN U.S., LYME DISEASE: SPOTLIGHT ON A HIDDEN EPIDEMIC.
In a Greenwich Time article published late last Thursday, Connecticut Attorney General Richard Blumenthal said he felt the hearing in Washington, D.C., on Lyme disease treatment guidelines that he helped bring about, was "unprecedented" and set a standard for transparency and fairness in crafting medical recommendations.
No comments:
Post a Comment